DNAJB11 and cancer: Specifically, DNAJB11 co-localized with AATZ (Z mutant of alpha-1-antitrypsin) protein can induce cirrhosis, increase cancer therapy tolerance, inhibit post-transcriptional degradation of AATZ, and promote tumorigenic AATZ polymer formation.